Colgate-Palmolive Co. Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>Colgate-Palmolive Co. has filed its Q1 2024 10-Q report detailing financial performance and equity changes.</b>

AI Summary

COLGATE PALMOLIVE CO (CL) filed a Quarterly Report (10-Q) with the SEC on April 26, 2024. Colgate-Palmolive Co. filed its quarterly report (10-Q) for the period ending March 31, 2024. The filing covers the period from January 1, 2024, to March 31, 2024. Key financial statement items and equity components are detailed for the reporting period and comparative periods. The company is incorporated in Delaware (DE) and its fiscal year ends on December 31. Colgate-Palmolive Co. operates in the Perfumes, Cosmetics & Other Toilet Preparations industry (SIC 2844).

Why It Matters

For investors and stakeholders tracking COLGATE PALMOLIVE CO, this filing contains several important signals. This 10-Q filing provides investors with the latest financial data for Colgate-Palmolive Co., enabling them to assess the company's performance and financial health in the first quarter of 2024. The detailed breakdown of financial statements and equity components allows for analysis of trends, profitability, and capital structure compared to previous periods.

Risk Assessment

Risk Level: low — COLGATE PALMOLIVE CO shows low risk based on this filing. The filing is a standard quarterly report (10-Q) and does not contain any immediate red flags or significant negative developments, indicating a low level of immediate risk from this filing alone.

Analyst Insight

Review the detailed financial statements and equity changes within the 10-Q to understand Colgate-Palmolive's Q1 2024 performance and compare it to prior periods.

Key Numbers

• 2024-03-31 — Period End Date (Conformed period of report)
• 2024-01-01 — Period Start Date (Reporting period start date)
• 2023-03-31 — Prior Period End Date (Comparative period end date)
• 2023-01-01 — Prior Period Start Date (Comparative period start date)

Key Players & Entities

• COLGATE PALMOLIVE CO (company) — Filer name
• 2024-03-31 (date) — Conformed period of report
• 2024-04-26 (date) — Filed as of date
• DE (jurisdiction) — State of incorporation
• 2123102000 (phone) — Business phone
• 300 PARK AVE (address) — Business address street 1
• NEW YORK (city) — Business address city
• 10022 (zip) — Business address zip

FAQ

Industry Context

Colgate-Palmolive Co. operates within the consumer staples sector, specifically in the personal care and household products market.

Regulatory Implications

The filing is made in accordance with the Securities Exchange Act of 1934, requiring public companies to submit regular financial disclosures.

What Investors Should Do

1. Analyze the consolidated balance sheets for March 31, 2024, and December 31, 2023.
2. Review the consolidated statements of operations for the three months ended March 31, 2024, and 2023.
3. Examine the consolidated statements of cash flows for the three months ended March 31, 2024, and 2023.

Key Dates

• 2024-03-31: Quarterly Period End — End of the reporting period for the 10-Q filing.
• 2024-04-26: Filing Date — Date the 10-Q report was officially filed with the SEC.

Year-Over-Year Comparison

This filing represents the first quarterly report for fiscal year 2024, providing updated financial information compared to the previous year's Q1 report.

Key Financial Figures

• $1.00 — ange on which registered Common Stock, $1.00 par value CL New York Stock Exchange

Filing Documents

• cl-20240331.htm (10-Q) — 1183KB
• exhibit10a_033124xq12024.htm (EX-10) — 131KB
• exhibit31a_033124xq12024.htm (EX-31.A) — 9KB
• exhibit31b_033124xq12024.htm (EX-31.B) — 9KB
• exhibit32_033124xq12024.htm (EX-32) — 5KB
• image_0.jpg (GRAPHIC) — 24KB
• 0000021665-24-000015.txt (&nbsp;) — 6296KB
• cl-20240331.xsd (EX-101.SCH) — 37KB
• cl-20240331_cal.xml (EX-101.CAL) — 66KB
• cl-20240331_def.xml (EX-101.DEF) — 207KB
• cl-20240331_lab.xml (EX-101.LAB) — 507KB
• cl-20240331_pre.xml (EX-101.PRE) — 369KB
• cl-20240331_htm.xml (XML) — 875KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION COLGATE-PALMOLIVE COMPANY Condensed Consolidated Statements of Income (Dollars in Millions Except Per Share Amounts) (Unaudited) Three Months Ended March 31, 2024 2023 Net sales $ 5,065 $ 4,770 Cost of sales 2,026 2,058 Gross profit 3,039 2,712 Selling, general and administrative expenses 1,916 1,758 Other (income) expense, net 76 45 Operating profit 1,047 909 Non-service related postretirement costs 22 294 Interest (income) expense, net 58 54 Income before income taxes 967 561 Provision for income taxes 238 147 Net income including noncontrolling interests 729 414 Less: Net income attributable to noncontrolling interests 46 42 Net income attributable to Colgate-Palmolive Company $ 683 $ 372 Earnings per common share, basic $ 0.83 $ 0.45 Earnings per common share, diluted $ 0.83 $ 0.45 See Notes to Condensed Consolidated Financial Statements. 2 COLGATE-PALMOLIVE COMPANY Condensed Consolidated Statements of Comprehensive Income (Dollars in Millions) (Unaudited) Three Months Ended March 31, 2024 2023 Net income including noncontrolling interests $ 729 $ 414 Other comprehensive income (loss), net of tax: Cumulative translation adjustments ( 94 ) 43 Retirement plans and other retiree benefit adjustments 4 7 Gains (losses) on cash flow hedges 1 6 Total Other comprehensive income (loss), net of tax ( 89 ) 56 Total Comprehensive income including noncontrolling interests 640 470 Less: Net income attributable to noncontrolling interests 46 42 Less: Cumulative translation adjustments attributable to noncontrolling interests ( 7 ) ( 16 ) Total Comprehensive income attributable to noncontrolling interests 39 26 Total Comprehensive income attributable to Colgate-Palmolive Company $ 601 $ 444 See Notes to Condensed Consolidated Financial Statements. 3 COLGATE-PALMOLIVE COMPANY Condensed Consolidated Balance Sheets (Dollars in Millions) (Unaudited) March 31, 2024 December 31, 2023 Assets C